TY - JOUR AU - Fitzmaurice, C. AU - Dicker, D. AU - Pain, A. AU - Hamavid, H. AU - Moradi-Lakeh, M. PY - 2015 DA - 2015// TI - The Global Burden of Cancer 2013 JO - JAMA Oncol VL - 1 UR - https://doi.org/10.1001/jamaoncol.2015.0735 DO - 10.1001/jamaoncol.2015.0735 ID - Fitzmaurice2015 ER - TY - JOUR AU - Nies, A. T. AU - Magdy, T. AU - Schwab, M. AU - Zanger, U. M. PY - 2015 DA - 2015// TI - Role of ABC transporters in fluoropyrimidine-based chemotherapy response JO - Adv Cancer Res. VL - 125 UR - https://doi.org/10.1016/bs.acr.2014.10.007 DO - 10.1016/bs.acr.2014.10.007 ID - Nies2015 ER - TY - JOUR AU - Hammond, W. A. AU - Swaika, A. AU - Mody, K. PY - 2016 DA - 2016// TI - Pharmacologic resistance in colorectal cancer: a review JO - Ther Adv Med Oncol. VL - 8 UR - https://doi.org/10.1177/1758834015614530 DO - 10.1177/1758834015614530 ID - Hammond2016 ER - TY - JOUR AU - Czabotar, P. E. AU - Lessene, G. AU - Strasser, A. AU - Adams, J. M. PY - 2014 DA - 2014// TI - Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy JO - Nat Rev Mol Cell Biol. VL - 15 UR - https://doi.org/10.1038/nrm3722 DO - 10.1038/nrm3722 ID - Czabotar2014 ER - TY - JOUR AU - Esteller, M. AU - Pandolfi, P. P. PY - 2017 DA - 2017// TI - The Epitranscriptome of Noncoding RNAs in Cancer JO - Cancer Discov. VL - 7 UR - https://doi.org/10.1158/2159-8290.CD-16-1292 DO - 10.1158/2159-8290.CD-16-1292 ID - Esteller2017 ER - TY - JOUR AU - Lu, L. AU - Sun, J. AU - Shi, P. AU - Kong, W. AU - Xu, K. AU - He, B. PY - 2017 DA - 2017// TI - Identification of circular RNAs as a promising new class of diagnostic biomarkers for human breast cancer JO - Oncotarget. VL - 8 ID - Lu2017 ER - TY - JOUR AU - Xing, F. AU - Wang, S. AU - Zhou, J. PY - 2019 DA - 2019// TI - The Expression of MicroRNA-598 Inhibits Ovarian Cancer Cell Proliferation and Metastasis by Targeting URI JO - Mol Ther Oncolytics. VL - 12 UR - https://doi.org/10.1016/j.omto.2018.12.002 DO - 10.1016/j.omto.2018.12.002 ID - Xing2019 ER - TY - JOUR AU - Wang, W. J. AU - Li, H. T. AU - Yu, J. P. AU - Han, X. P. AU - Xu, Z. P. AU - Li, Y. M. PY - 2019 DA - 2019// TI - A Competing Endogenous RNA Network Reveals Novel Potential lncRNA, miRNA, and mRNA Biomarkers in the Prognosis of Human Colon Adenocarcinoma JO - J Surg Res. VL - 235 UR - https://doi.org/10.1016/j.jss.2018.09.053 DO - 10.1016/j.jss.2018.09.053 ID - Wang2019 ER - TY - JOUR AU - Mai, D. AU - Ding, P. AU - Tan, L. AU - Zhang, J. AU - Pan, Z. AU - Bai, R. PY - 2018 DA - 2018// TI - PIWI-interacting RNA-54265 is oncogenic and a potential therapeutic target in colorectal adenocarcinoma JO - Theranostics. VL - 8 UR - https://doi.org/10.7150/thno.28001 DO - 10.7150/thno.28001 ID - Mai2018 ER - TY - JOUR AU - Wang, H. AU - Ma, P. AU - Liu, P. AU - Chen, B. AU - Liu, Z. PY - 2018 DA - 2018// TI - Small nucleolar RNA U2_19 promotes hepatocellular carcinoma progression by regulating Wnt/beta-catenin signaling JO - Biochem Biophys Res Commun. VL - 500 UR - https://doi.org/10.1016/j.bbrc.2018.04.074 DO - 10.1016/j.bbrc.2018.04.074 ID - Wang2018 ER - TY - JOUR AU - Okugawa, Y. AU - Toiyama, Y. AU - Toden, S. AU - Mitoma, H. AU - Nagasaka, T. AU - Tanaka, K. PY - 2017 DA - 2017// TI - Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer JO - Gut. VL - 66 UR - https://doi.org/10.1136/gutjnl-2015-309359 DO - 10.1136/gutjnl-2015-309359 ID - Okugawa2017 ER - TY - JOUR AU - Yi, C. AU - Wan, X. AU - Zhang, Y. AU - Fu, F. AU - Zhao, C. AU - Qin, R. PY - 2018 DA - 2018// TI - SNORA42 enhances prostate cancer cell viability, migration and EMT and is correlated with prostate cancer poor prognosis JO - Int J Biochem Cell Biol. VL - 102 UR - https://doi.org/10.1016/j.biocel.2018.07.009 DO - 10.1016/j.biocel.2018.07.009 ID - Yi2018 ER - TY - JOUR AU - Vychytilova-Faltejskova, P. AU - Stitkovcova, K. AU - Radova, L. AU - Sachlova, M. AU - Kosarova, Z. AU - Slaba, K. PY - 2018 DA - 2018// TI - Circulating PIWI-Interacting RNAs piR-5937 and piR-28876 Are Promising Diagnostic Biomarkers of Colon Cancer JO - Cancer Epidemiol Biomarkers Prev. VL - 27 UR - https://doi.org/10.1158/1055-9965.EPI-18-0318 DO - 10.1158/1055-9965.EPI-18-0318 ID - Vychytilova-Faltejskova2018 ER - TY - JOUR AU - Wu, L. AU - Zheng, J. AU - Chen, P. AU - Liu, Q. AU - Yuan, Y. PY - 2017 DA - 2017// TI - Small nucleolar RNA ACA11 promotes proliferation, migration and invasion in hepatocellular carcinoma by targeting the PI3K/AKT signaling pathway JO - Biomed Pharmacother. VL - 90 UR - https://doi.org/10.1016/j.biopha.2017.04.014 DO - 10.1016/j.biopha.2017.04.014 ID - Wu2017 ER - TY - JOUR AU - Qin, X. G. AU - Zeng, J. H. AU - Lin, P. AU - Mo, W. J. AU - Li, Q. AU - Feng, Z. B. PY - 2019 DA - 2019// TI - Prognostic value of small nuclear RNAs (snRNAs) for digestive tract pan- adenocarcinomas identified by RNA sequencing data JO - Pathol Res Pract. VL - 215 UR - https://doi.org/10.1016/j.prp.2018.11.004 DO - 10.1016/j.prp.2018.11.004 ID - Qin2019 ER - TY - JOUR AU - Cech, T. R. AU - Steitz, J. A. PY - 2014 DA - 2014// TI - The noncoding RNA revolution-trashing old rules to forge new ones JO - Cell. VL - 157 UR - https://doi.org/10.1016/j.cell.2014.03.008 DO - 10.1016/j.cell.2014.03.008 ID - Cech2014 ER - TY - JOUR AU - Dhamija, S. AU - Diederichs, S. PY - 2016 DA - 2016// TI - From junk to master regulators of invasion: lncRNA functions in migration, EMT and metastasis JO - Int J Cancer. VL - 139 UR - https://doi.org/10.1002/ijc.30039 DO - 10.1002/ijc.30039 ID - Dhamija2016 ER - TY - JOUR AU - Wu, H. AU - Liu, C. AU - Yang, Q. AU - Xin, C. AU - Du, J. AU - Sun, F. PY - 2019 DA - 2019// TI - MIR145-3p promotes autophagy and enhances bortezomib sensitivity in multiple myeloma by targeting HDAC4 JO - Autophagy. VL - 16 ID - Wu2019 ER - TY - JOUR AU - Gao, S. AU - Yu, Y. AU - Liu, L. AU - Meng, J. AU - Li, G. PY - 2019 DA - 2019// TI - Circular RNA hsa_circ_0007059 restrains proliferation and epithelial-mesenchymal transition in lung cancer cells via inhibiting microRNA-378 JO - Life Sci. VL - 233 UR - https://doi.org/10.1016/j.lfs.2019.116692 DO - 10.1016/j.lfs.2019.116692 ID - Gao2019 ER - TY - JOUR AU - Liu, J. AU - Song, S. AU - Lin, S. AU - Zhang, M. AU - Du, Y. AU - Zhang, D. PY - 2019 DA - 2019// TI - Circ-SERPINE2 promotes the development of gastric carcinoma by sponging miR-375 and modulating YWHAZ JO - Cell Prolif. VL - 52 ID - Liu2019 ER - TY - JOUR AU - Guo, Z. AU - Zhang, J. AU - Fan, L. AU - Liu, J. AU - Yu, H. AU - Li, X. PY - 2019 DA - 2019// TI - Long Noncoding RNA (lncRNA) Small Nucleolar RNA Host Gene 16 (SNHG16) Predicts Poor Prognosis and Sorafenib Resistance in Hepatocellular Carcinoma JO - Med Sci Monit. VL - 25 UR - https://doi.org/10.12659/MSM.915541 DO - 10.12659/MSM.915541 ID - Guo2019 ER - TY - JOUR AU - Zhang, Q. AU - Zhang, C. AU - Ma, J. X. AU - Ren, H. AU - Sun, Y. AU - Xu, J. Z. PY - 2019 DA - 2019// TI - Circular RNA PIP5K1A promotes colon cancer development through inhibiting miR-1273a JO - World J Gastroenterol. VL - 25 UR - https://doi.org/10.3748/wjg.v25.i35.5300 DO - 10.3748/wjg.v25.i35.5300 ID - Zhang2019 ER - TY - STD TI - Liu YY, Zhang LY, Du WZ. Circular RNA circ-PVT1 contributes to paclitaxel resistance of gastric cancer cells through the regulation of ZEB1 expression by sponging miR-124-3p. Biosci Rep. 2019;39(12):BSR20193045. ID - ref23 ER - TY - JOUR AU - Chun-Zhi, Z. AU - Lei, H. AU - An-Ling, Z. AU - Yan-Chao, F. AU - Xiao, Y. AU - Guang-Xiu, W. PY - 2010 DA - 2010// TI - MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN JO - BMC Cancer. VL - 10 UR - https://doi.org/10.1186/1471-2407-10-367 DO - 10.1186/1471-2407-10-367 ID - Chun-Zhi2010 ER - TY - JOUR AU - Zhu, C. AU - Huang, Q. AU - Zhu, H. PY - 2019 DA - 2019// TI - miR-383 Inhibited the Cell Cycle Progression of Gastric Cancer Cells via Targeting Cyclin E2 JO - DNA Cell Biol. VL - 38 UR - https://doi.org/10.1089/dna.2019.4624 DO - 10.1089/dna.2019.4624 ID - Zhu2019 ER - TY - JOUR AU - Zhang, F. AU - Li, Y. AU - Xu, W. AU - He, L. AU - Tan, Y. AU - Xu, H. PY - 2019 DA - 2019// TI - Long non-coding RNA ZFAS1 regulates the malignant progression of gastric cancer via the microRNA-200b-3p/Wnt1 axis JO - Biosci Biotechnol Biochem. VL - 83 UR - https://doi.org/10.1080/09168451.2019.1606697 DO - 10.1080/09168451.2019.1606697 ID - Zhang2019 ER - TY - JOUR AU - Xi, Z. AU - Si, J. AU - Nan, J. PY - 2019 DA - 2019// TI - LncRNA MALAT1 potentiates autophagyassociated cisplatin resistance by regulating the microRNA30b/autophagyrelated gene 5 axis in gastric cancer JO - Int J Oncol. VL - 54 ID - Xi2019 ER - TY - JOUR AU - Lee, S. D. AU - Yu, D. AU - Lee, D. Y. AU - Shin, H. S. AU - Jo, J. H. AU - Lee, Y. C. PY - 2019 DA - 2019// TI - Upregulated microRNA-193a-3p is responsible for cisplatin resistance in CD44(+) gastric cancer cells JO - Cancer Sci. VL - 110 UR - https://doi.org/10.1111/cas.13894 DO - 10.1111/cas.13894 ID - Lee2019 ER - TY - JOUR AU - Liu, X. H. AU - Sun, M. AU - Nie, F. Q. AU - Ge, Y. B. AU - Zhang, E. B. AU - Yin, D. D. PY - 2014 DA - 2014// TI - Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer JO - Mol Cancer. VL - 13 UR - https://doi.org/10.1186/1476-4598-13-92 DO - 10.1186/1476-4598-13-92 ID - Liu2014 ER - TY - JOUR AU - Wei, Y. AU - Liu, Z. AU - Fang, J. PY - 2018 DA - 2018// TI - H19 functions as a competing endogenous RNA to regulate human epidermal growth factor receptor expression by sequestering let7c in gastric cancer JO - Mol Med Rep. VL - 17 ID - Wei2018 ER - TY - JOUR AU - Masuda, K. AU - Shoji, H. AU - Nagashima, K. AU - Yamamoto, S. AU - Ishikawa, M. AU - Imazeki, H. PY - 2019 DA - 2019// TI - Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab JO - BMC Cancer. VL - 19 UR - https://doi.org/10.1186/s12885-019-6150-y DO - 10.1186/s12885-019-6150-y ID - Masuda2019 ER - TY - JOUR AU - Aoki, M. AU - Shoji, H. AU - Nagashima, K. AU - Imazeki, H. AU - Miyamoto, T. AU - Hirano, H. PY - 2019 DA - 2019// TI - Hyperprogressive disease during nivolumab or irinotecan treatment in patients with advanced gastric cancer JO - ESMO Open. VL - 4 UR - https://doi.org/10.1136/esmoopen-2019-000488 DO - 10.1136/esmoopen-2019-000488 ID - Aoki2019 ER - TY - JOUR AU - Sunakawa, Y. AU - Inoue, E. AU - Matoba, R. AU - Kawakami, H. AU - Sato, Y. AU - Nakajima, T. E. PY - 2019 DA - 2019// TI - DELIVER (JACCRO GC-08) trial: discover novel host-related immune-biomarkers for nivolumab in advanced gastric cancer JO - Future Oncol. VL - 15 UR - https://doi.org/10.2217/fon-2019-0167 DO - 10.2217/fon-2019-0167 ID - Sunakawa2019 ER - TY - JOUR AU - Bang, Y. J. AU - Kang, Y. K. AU - Catenacci, D. V. AU - Muro, K. AU - Fuchs, C. S. AU - Geva, R. PY - 2019 DA - 2019// TI - Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study JO - Gastric Cancer. VL - 22 UR - https://doi.org/10.1007/s10120-018-00909-5 DO - 10.1007/s10120-018-00909-5 ID - Bang2019 ER - TY - JOUR AU - Bang, Y. J. AU - Cutsem, E. AU - Fuchs, C. S. AU - Ohtsu, A. AU - Tabernero, J. AU - Ilson, D. H. PY - 2019 DA - 2019// TI - KEYNOTE-585: Phase III study of perioperative chemotherapy with or without pembrolizumab for gastric cancer JO - Future Oncol. VL - 15 UR - https://doi.org/10.2217/fon-2018-0581 DO - 10.2217/fon-2018-0581 ID - Bang2019 ER - TY - JOUR AU - Kulangara, K. AU - Zhang, N. AU - Corigliano, E. AU - Guerrero, L. AU - Waldroup, S. AU - Jaiswal, D. PY - 2019 DA - 2019// TI - Clinical Utility of the Combined Positive Score for Programmed Death Ligand-1 Expression and the Approval of Pembrolizumab for Treatment of Gastric Cancer JO - Arch Pathol Lab Med. VL - 143 UR - https://doi.org/10.5858/arpa.2018-0043-OA DO - 10.5858/arpa.2018-0043-OA ID - Kulangara2019 ER - TY - JOUR AU - Roviello, G. AU - D'Angelo, A. AU - Generali, D. AU - Pittacolo, M. AU - Ganzinelli, M. AU - Iezzi, G. PY - 2019 DA - 2019// TI - Avelumab in gastric cancer JO - Immunotherapy. VL - 11 UR - https://doi.org/10.2217/imt-2019-0011 DO - 10.2217/imt-2019-0011 ID - Roviello2019 ER - TY - JOUR AU - Hause, R. J. AU - Pritchard, C. C. AU - Shendure, J. AU - Salipante, S. J. PY - 2016 DA - 2016// TI - Classification and characterization of microsatellite instability across 18 cancer types JO - Nat Med. VL - 22 UR - https://doi.org/10.1038/nm.4191 DO - 10.1038/nm.4191 ID - Hause2016 ER - TY - JOUR AU - Le, D. T. AU - Durham, J. N. AU - Smith, K. N. AU - Wang, H. AU - Bartlett, B. R. AU - Aulakh, L. K. PY - 2017 DA - 2017// TI - Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade JO - Science. VL - 357 UR - https://doi.org/10.1126/science.aan6733 DO - 10.1126/science.aan6733 ID - Le2017 ER - TY - JOUR AU - Rizvi, N. A. AU - Hellmann, M. D. AU - Snyder, A. AU - Kvistborg, P. AU - Makarov, V. AU - Havel, J. J. PY - 2015 DA - 2015// TI - Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer JO - Science. VL - 348 UR - https://doi.org/10.1126/science.aaa1348 DO - 10.1126/science.aaa1348 ID - Rizvi2015 ER - TY - JOUR AU - Ock, C. Y. AU - Keam, B. AU - Kim, S. AU - Lee, J. S. AU - Kim, M. AU - Kim, T. M. PY - 2016 DA - 2016// TI - Pan-Cancer Immunogenomic Perspective on the Tumor Microenvironment Based on PD-L1 and CD8 T-Cell Infiltration JO - Clin Cancer Res. VL - 22 UR - https://doi.org/10.1158/1078-0432.CCR-15-2834 DO - 10.1158/1078-0432.CCR-15-2834 ID - Ock2016 ER - TY - JOUR AU - Shukla, G. C. AU - Singh, J. AU - Barik, S. PY - 2011 DA - 2011// TI - MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions JO - Mol Cell Pharmacol. VL - 3 ID - Shukla2011 ER - TY - JOUR AU - Markopoulos, G. S. AU - Roupakia, E. AU - Tokamani, M. AU - Chavdoula, E. AU - Hatziapostolou, M. AU - Polytarchou, C. PY - 2017 DA - 2017// TI - A step-by-step microRNA guide to cancer development and metastasis JO - Cell Oncol (Dordr). VL - 40 UR - https://doi.org/10.1007/s13402-017-0341-9 DO - 10.1007/s13402-017-0341-9 ID - Markopoulos2017 ER - TY - JOUR AU - Ebrahimi, S. AU - Hashemy, S. I. PY - 2019 DA - 2019// TI - MicroRNA-mediated redox regulation modulates therapy resistance in cancer cells: clinical perspectives JO - Cell Oncol (Dordr). VL - 42 UR - https://doi.org/10.1007/s13402-018-00421-z DO - 10.1007/s13402-018-00421-z ID - Ebrahimi2019 ER - TY - JOUR AU - Stuart-Smith, K. AU - Vanhoutte, P. M. PY - 1988 DA - 1988// TI - Arachidonic acid evokes epithelium-dependent relaxations in canine airways JO - J Appl Physiol (1985) VL - 65 UR - https://doi.org/10.1152/jappl.1988.65.5.2170 DO - 10.1152/jappl.1988.65.5.2170 ID - Stuart-Smith1988 ER - TY - JOUR AU - Wei, W. AU - Cao, W. AU - Zhan, Z. AU - Yan, L. AU - Xie, Y. AU - Xiao, Q. PY - 2019 DA - 2019// TI - MiR-1284 suppresses gastric cancer progression by targeting EIF4A1 JO - Onco Targets Ther. VL - 12 UR - https://doi.org/10.2147/OTT.S191015 DO - 10.2147/OTT.S191015 ID - Wei2019 ER - TY - JOUR AU - Li, M. AU - Gao, M. AU - Xie, X. AU - Zhang, Y. AU - Ning, J. AU - Liu, P. PY - 2019 DA - 2019// TI - MicroRNA-200c reverses drug resistance of human gastric cancer cells by targeting regulation of the NER-ERCC3/4 pathway JO - Oncol Lett. VL - 18 ID - Li2019 ER - TY - JOUR AU - Ning, J. AU - Jiao, Y. AU - Xie, X. AU - Deng, X. AU - Zhang, Y. AU - Yang, Y. PY - 2019 DA - 2019// TI - miR1385p modulates the expression of excision repair crosscomplementing proteins ERCC1 and ERCC4, and regulates the sensitivity of gastric cancer cells to cisplatin JO - Oncol Rep. VL - 41 ID - Ning2019 ER - TY - JOUR AU - Chua, P. J. AU - Lim, J. P. AU - Guo, T. T. AU - Khanna, P. AU - Hu, Q. AU - Bay, B. H. PY - 2018 DA - 2018// TI - Y-box binding protein-1 and STAT3 independently regulate ATP-binding cassette transporters in the chemoresistance of gastric cancer cells JO - Int J Oncol. VL - 53 ID - Chua2018 ER - TY - JOUR AU - Kang, X. AU - Li, M. AU - Zhu, H. AU - Lu, X. AU - Miao, J. AU - Du, S. PY - 2017 DA - 2017// TI - DUSP4 promotes doxorubicin resistance in gastric cancer through epithelial-mesenchymal transition JO - Oncotarget. VL - 8 ID - Kang2017 ER - TY - JOUR AU - Hong, K. S. AU - Kim, H. AU - Kim, S. H. AU - Kim, M. AU - Yoo, J. PY - 2019 DA - 2019// TI - Calponin 3 Regulates Cell Invasion and Doxorubicin Resistance in Gastric Cancer JO - Gastroenterol Res Pract. VL - 2019 UR - https://doi.org/10.1155/2019/3024970 DO - 10.1155/2019/3024970 ID - Hong2019 ER - TY - JOUR AU - Xu, Z. AU - Chen, L. AU - Xiao, Z. AU - Zhu, Y. AU - Jiang, H. AU - Jin, Y. PY - 2018 DA - 2018// TI - Potentiation of the anticancer effect of doxorubicinin drug-resistant gastric cancer cells by tanshinone IIA JO - Phytomedicine. VL - 51 UR - https://doi.org/10.1016/j.phymed.2018.05.012 DO - 10.1016/j.phymed.2018.05.012 ID - Xu2018 ER - TY - JOUR AU - Zhou, W. AU - Tan, W. AU - Huang, X. AU - Yu, H. G. PY - 2018 DA - 2018// TI - Doxorubicin combined with Notch1-targeting siRNA for the treatment of gastric cancer JO - Oncol Lett. VL - 16 ID - Zhou2018 ER - TY - JOUR AU - Zhao, X. AU - Yang, L. AU - Hu, J. PY - 2011 DA - 2011// TI - Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells JO - J Exp Clin Cancer Res. VL - 30 UR - https://doi.org/10.1186/1756-9966-30-55 DO - 10.1186/1756-9966-30-55 ID - Zhao2011 ER - TY - JOUR AU - Pan, Y. AU - Ren, F. AU - Zhang, W. AU - Liu, G. AU - Yang, D. AU - Hu, J. PY - 2014 DA - 2014// TI - Regulation of BGC-823 cell sensitivity to adriamycin via miRNA-135a-5p JO - Oncol Rep. VL - 32 UR - https://doi.org/10.3892/or.2014.3546 DO - 10.3892/or.2014.3546 ID - Pan2014 ER - TY - JOUR AU - Kim, H. AU - Choi, H. AU - Lee, S. K. PY - 2015 DA - 2015// TI - Epstein-Barr virus miR-BART20-5p regulates cell proliferation and apoptosis by targeting BAD JO - Cancer Lett VL - 356 UR - https://doi.org/10.1016/j.canlet.2014.10.023 DO - 10.1016/j.canlet.2014.10.023 ID - Kim2015 ER - TY - JOUR AU - Wang, F. AU - Li, T. AU - Zhang, B. AU - Li, H. AU - Wu, Q. AU - Yang, L. PY - 2013 DA - 2013// TI - MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN JO - Biochem Biophys Res Commun. VL - 434 UR - https://doi.org/10.1016/j.bbrc.2013.04.010 DO - 10.1016/j.bbrc.2013.04.010 ID - Wang2013 ER - TY - JOUR AU - Xu, Y. C. AU - Liu, X. AU - Li, M. AU - Li, Y. AU - Li, C. Y. AU - Lu, Y. PY - 2018 DA - 2018// TI - A Novel Mechanism of Doxorubicin Resistance and Tumorigenesis Mediated by MicroRNA-501-5p-Suppressed BLID JO - Mol Ther Nucleic Acids. VL - 12 UR - https://doi.org/10.1016/j.omtn.2018.06.011 DO - 10.1016/j.omtn.2018.06.011 ID - Xu2018 ER - TY - JOUR AU - Liu, X. AU - Lu, Y. AU - Xu, Y. AU - Hou, S. AU - Huang, J. AU - Wang, B. PY - 2019 DA - 2019// TI - Exosomal transfer of miR-501 confers doxorubicin resistance and tumorigenesis via targeting of BLID in gastric cancer JO - Cancer Lett. VL - 459 UR - https://doi.org/10.1016/j.canlet.2019.05.035 DO - 10.1016/j.canlet.2019.05.035 ID - Liu2019 ER - TY - JOUR AU - Li, X. AU - Zhang, Z. AU - Yu, M. AU - Li, L. AU - Du, G. AU - Xiao, W. PY - 2013 DA - 2013// TI - Involvement of miR-20a in promoting gastric cancer progression by targeting early growth response 2 (EGR2) JO - Int J Mol Sci. VL - 14 UR - https://doi.org/10.3390/ijms140816226 DO - 10.3390/ijms140816226 ID - Li2013 ER - TY - JOUR AU - Chen, J. AU - Zhou, C. AU - Li, J. AU - Xiang, X. AU - Zhang, L. AU - Deng, J. PY - 2018 DA - 2018// TI - miR215p confers doxorubicin resistance in gastric cancer cells by targeting PTEN and TIMP3 JO - Int J Mol Med. VL - 41 ID - Chen2018 ER - TY - JOUR AU - Pang, X. AU - Zhou, Z. AU - Yu, Z. AU - Han, L. AU - Lin, Z. AU - Ao, X. PY - 2019 DA - 2019// TI - Foxo3a-dependent miR-633 regulates chemotherapeutic sensitivity in gastric cancer by targeting Fas-associated death domain JO - RNA Biol. VL - 16 UR - https://doi.org/10.1080/15476286.2019.1565665 DO - 10.1080/15476286.2019.1565665 ID - Pang2019 ER - TY - JOUR AU - Shen, Q. AU - Yao, Q. AU - Sun, J. AU - Feng, L. AU - Lu, H. AU - Ma, Y. PY - 2014 DA - 2014// TI - Downregulation of histone deacetylase 1 by microRNA-520h contributes to the chemotherapeutic effect of doxorubicin JO - FEBS Lett. VL - 588 UR - https://doi.org/10.1016/j.febslet.2013.11.034 DO - 10.1016/j.febslet.2013.11.034 ID - Shen2014 ER - TY - JOUR AU - Wu, Q. AU - Yang, Z. AU - Xia, L. AU - Nie, Y. AU - Wu, K. AU - Shi, Y. PY - 2014 DA - 2014// TI - Methylation of miR-129-5p CpG island modulates multi-drug resistance in gastric cancer by targeting ABC transporters JO - Oncotarget. VL - 5 UR - https://doi.org/10.18632/oncotarget.2594 DO - 10.18632/oncotarget.2594 ID - Wu2014 ER - TY - JOUR AU - Shang, Y. AU - Zhang, Z. AU - Liu, Z. AU - Feng, B. AU - Ren, G. AU - Li, K. PY - 2014 DA - 2014// TI - miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1 JO - Oncogene. VL - 33 UR - https://doi.org/10.1038/onc.2013.297 DO - 10.1038/onc.2013.297 ID - Shang2014 ER - TY - JOUR AU - Zhang, Y. AU - Qu, X. AU - Li, C. AU - Fan, Y. AU - Che, X. AU - Wang, X. PY - 2015 DA - 2015// TI - miR-103/107 modulates multidrug resistance in human gastric carcinoma by downregulating Cav-1 JO - Tumour Biol. VL - 36 UR - https://doi.org/10.1007/s13277-014-2835-7 DO - 10.1007/s13277-014-2835-7 ID - Zhang2015 ER - TY - JOUR AU - Shang, Y. AU - Feng, B. AU - Zhou, L. AU - Ren, G. AU - Zhang, Z. AU - Fan, X. PY - 2016 DA - 2016// TI - The miR27b-CCNG1-P53-miR-508-5p axis regulates multidrug resistance of gastric cancer JO - Oncotarget. VL - 7 UR - https://doi.org/10.18632/oncotarget.6374 DO - 10.18632/oncotarget.6374 ID - Shang2016 ER - TY - JOUR AU - Zou, J. AU - Xu, Y. PY - 2016 DA - 2016// TI - MicroRNA-140 Inhibits Cell Proliferation in Gastric Cancer Cell Line HGC-27 by Suppressing SOX4 JO - Med Sci Monit. VL - 22 UR - https://doi.org/10.12659/MSM.896633 DO - 10.12659/MSM.896633 ID - Zou2016 ER - TY - JOUR AU - Teng, R. AU - Hu, Y. AU - Zhou, J. AU - Seifer, B. AU - Chen, Y. AU - Shen, J. PY - 2015 DA - 2015// TI - Overexpression of Lin28 Decreases the Chemosensitivity of Gastric Cancer Cells to Oxaliplatin, Paclitaxel, Doxorubicin, and Fluorouracil in Part via microRNA-107 JO - PLoS One. VL - 10 UR - https://doi.org/10.1371/journal.pone.0143716 DO - 10.1371/journal.pone.0143716 ID - Teng2015 ER - TY - JOUR AU - Xia, L. AU - Zhang, D. AU - Du, R. AU - Pan, Y. AU - Zhao, L. AU - Sun, S. PY - 2008 DA - 2008// TI - miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells JO - Int J Cancer. VL - 123 UR - https://doi.org/10.1002/ijc.23501 DO - 10.1002/ijc.23501 ID - Xia2008 ER - TY - JOUR AU - Zhu, W. AU - Shan, X. AU - Wang, T. AU - Shu, Y. AU - Liu, P. PY - 2010 DA - 2010// TI - miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines JO - Int J Cancer. VL - 127 UR - https://doi.org/10.1002/ijc.25260 DO - 10.1002/ijc.25260 ID - Zhu2010 ER - TY - JOUR AU - Zhu, W. AU - Zhu, D. AU - Lu, S. AU - Wang, T. AU - Wang, J. AU - Jiang, B. PY - 2012 DA - 2012// TI - miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2 JO - Med Oncol. VL - 29 UR - https://doi.org/10.1007/s12032-010-9797-4 DO - 10.1007/s12032-010-9797-4 ID - Zhu2012 ER - TY - JOUR AU - Zhu, W. AU - Xu, H. AU - Zhu, D. AU - Zhi, H. AU - Wang, T. AU - Wang, J. PY - 2012 DA - 2012// TI - miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP JO - Cancer Chemother Pharmacol. VL - 69 UR - https://doi.org/10.1007/s00280-011-1752-3 DO - 10.1007/s00280-011-1752-3 ID - Zhu2012 ER - TY - JOUR AU - Ji, Q. AU - Hao, X. AU - Meng, Y. AU - Zhang, M. AU - Desano, J. AU - Fan, D. PY - 2008 DA - 2008// TI - Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres JO - BMC Cancer. VL - 8 UR - https://doi.org/10.1186/1471-2407-8-266 DO - 10.1186/1471-2407-8-266 ID - Ji2008 ER - TY - JOUR AU - Chen, Y. AU - Zuo, J. AU - Liu, Y. AU - Gao, H. AU - Liu, W. PY - 2010 DA - 2010// TI - Inhibitory effects of miRNA-200c on chemotherapy-resistance and cell proliferation of gastric cancer SGC7901/DDP cells JO - Chin J Cancer. VL - 29 UR - https://doi.org/10.5732/cjc.010.10236 DO - 10.5732/cjc.010.10236 ID - Chen2010 ER - TY - JOUR AU - Li, Q. AU - Wang, J. X. AU - He, Y. Q. AU - Feng, C. AU - Zhang, X. J. AU - Sheng, J. Q. PY - 2014 DA - 2014// TI - MicroRNA-185 regulates chemotherapeutic sensitivity in gastric cancer by targeting apoptosis repressor with caspase recruitment domain JO - Cell Death Dis. VL - 5 UR - https://doi.org/10.1038/cddis.2014.148 DO - 10.1038/cddis.2014.148 ID - Li2014 ER - TY - JOUR AU - Wang, P. AU - Li, Z. AU - Liu, H. AU - Zhou, D. AU - Fu, A. AU - Zhang, E. PY - 2016 DA - 2016// TI - MicroRNA-126 increases chemosensitivity in drug-resistant gastric cancer cells by targeting EZH2 JO - Biochem Biophys Res Commun. VL - 479 UR - https://doi.org/10.1016/j.bbrc.2016.09.040 DO - 10.1016/j.bbrc.2016.09.040 ID - Wang2016 ER - TY - JOUR AU - Zhang, X. L. AU - Shi, H. J. AU - Wang, J. P. AU - Tang, H. S. AU - Cui, S. Z. PY - 2015 DA - 2015// TI - MiR-218 inhibits multidrug resistance (MDR) of gastric cancer cells by targeting Hedgehog/smoothened JO - Int J Clin Exp Pathol. VL - 8 ID - Zhang2015 ER - TY - JOUR AU - Peng, Q. P. AU - Du, D. B. AU - Ming, Q. AU - Hu, F. AU - Wu, Z. B. AU - Qiu, S. PY - 2018 DA - 2018// TI - MicroRNA 494 increases chemosensitivity to doxorubicin in gastric cancer cells by targeting phosphodiesterases 4D JO - Cell Mol Biol (Noisy-le-grand). VL - 64 UR - https://doi.org/10.14715/cmb/2017.64.15.10 DO - 10.14715/cmb/2017.64.15.10 ID - Peng2018 ER - TY - JOUR AU - Deng, H. AU - Guo, Y. AU - Song, H. AU - Xiao, B. AU - Sun, W. AU - Liu, Z. PY - 2013 DA - 2013// TI - MicroRNA-195 and microRNA-378 mediate tumor growth suppression by epigenetical regulation in gastric cancer JO - Gene. VL - 518 UR - https://doi.org/10.1016/j.gene.2012.12.103 DO - 10.1016/j.gene.2012.12.103 ID - Deng2013 ER - TY - JOUR AU - Schenk, E. L. AU - Mandrekar, S. J. AU - Dy, G. K. AU - Aubry, M. C. AU - Tan, A. D. AU - Dakhil, S. R. PY - 2019 DA - 2019// TI - A randomized double-blind phase II study of the Seneca Valley Virus (NTX-010) vs placebo for patients with extensive stage SCLC (ES-SCLC) who were stable or responding after at least 4 cycles of platinum-based chemotherapy: NCCTG (Alliance) N0923 Study JO - J Thorac Oncol. VL - 15 UR - https://doi.org/10.1016/j.jtho.2019.09.083 DO - 10.1016/j.jtho.2019.09.083 ID - Schenk2019 ER - TY - JOUR AU - Sun, J. AU - Bao, S. AU - Xu, D. AU - Zhang, Y. AU - Su, J. AU - Liu, J. PY - 2019 DA - 2019// TI - Large-scale integrated analysis of ovarian cancer tumors and cell lines identifies an individualized gene expression signature for predicting response to platinum-based chemotherapy JO - Cell Death Dis. VL - 10 UR - https://doi.org/10.1038/s41419-019-1874-9 DO - 10.1038/s41419-019-1874-9 ID - Sun2019 ER - TY - JOUR AU - Zhu, M. AU - Zhou, X. AU - Du, Y. AU - Huang, Z. AU - Zhu, J. AU - Xu, J. PY - 2016 DA - 2016// TI - miR-20a induces cisplatin resistance of a human gastric cancer cell line via targeting CYLD JO - Mol Med Rep. VL - 14 UR - https://doi.org/10.3892/mmr.2016.5413 DO - 10.3892/mmr.2016.5413 ID - Zhu2016 ER - TY - JOUR AU - Fang, Y. AU - Shen, H. AU - Li, H. AU - Cao, Y. AU - Qin, R. AU - Long, L. PY - 2013 DA - 2013// TI - miR-106a confers cisplatin resistance by regulating PTEN/Akt pathway in gastric cancer cells JO - Acta Biochim Biophys Sin (Shanghai) VL - 45 UR - https://doi.org/10.1093/abbs/gmt106 DO - 10.1093/abbs/gmt106 ID - Fang2013 ER - TY - JOUR AU - Zhang, Y. AU - Lu, Q. AU - Cai, X. PY - 2013 DA - 2013// TI - MicroRNA-106a induces multidrug resistance in gastric cancer by targeting RUNX3 JO - FEBS Lett. VL - 587 UR - https://doi.org/10.1016/j.febslet.2013.06.058 DO - 10.1016/j.febslet.2013.06.058 ID - Zhang2013 ER - TY - JOUR AU - Yang, S. M. AU - Huang, C. AU - Li, X. F. AU - Yu, M. Z. AU - He, Y. AU - Li, J. PY - 2013 DA - 2013// TI - miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN JO - Toxicology. VL - 306 UR - https://doi.org/10.1016/j.tox.2013.02.014 DO - 10.1016/j.tox.2013.02.014 ID - Yang2013 ER - TY - JOUR AU - He, J. AU - Qi, H. AU - Chen, F. AU - Cao, C. PY - 2017 DA - 2017// TI - MicroRNA-25 contributes to cisplatin resistance in gastric cancer cells by inhibiting forkhead box O3a JO - Oncol Lett. VL - 14 ID - He2017 ER - TY - JOUR AU - Zhou, X. AU - Su, J. AU - Zhu, L. AU - Zhang, G. PY - 2014 DA - 2014// TI - Helicobacter pylori modulates cisplatin sensitivity in gastric cancer by down-regulating miR-141 expression JO - Helicobacter. VL - 19 UR - https://doi.org/10.1111/hel.12120 DO - 10.1111/hel.12120 ID - Zhou2014 ER - TY - JOUR AU - Zhou, X. AU - Jin, W. AU - Jia, H. AU - Yan, J. AU - Zhang, G. PY - 2015 DA - 2015// TI - MiR-223 promotes the cisplatin resistance of human gastric cancer cells via regulating cell cycle by targeting FBXW7 JO - J Exp Clin Cancer Res. VL - 34 UR - https://doi.org/10.1186/s13046-015-0145-6 DO - 10.1186/s13046-015-0145-6 ID - Zhou2015 ER - TY - JOUR AU - Zhang, Y. AU - Xu, W. AU - Ni, P. AU - Li, A. AU - Zhou, J. AU - Xu, S. PY - 2016 DA - 2016// TI - MiR-99a and MiR-491 Regulate Cisplatin Resistance in Human Gastric Cancer Cells by Targeting CAPNS1 JO - Int J Biol Sci. VL - 12 UR - https://doi.org/10.7150/ijbs.16529 DO - 10.7150/ijbs.16529 ID - Zhang2016 ER - TY - JOUR AU - Ge, X. AU - Liu, X. AU - Lin, F. AU - Li, P. AU - Liu, K. AU - Geng, R. PY - 2016 DA - 2016// TI - MicroRNA-421 regulated by HIF-1alpha promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer JO - Oncotarget. VL - 7 UR - https://doi.org/10.18632/oncotarget.8228 DO - 10.18632/oncotarget.8228 ID - Ge2016 ER - TY - JOUR AU - Shao, L. AU - Chen, Z. AU - Soutto, M. AU - Zhu, S. AU - Lu, H. AU - Romero-Gallo, J. PY - 2019 DA - 2019// TI - Helicobacter pylori-induced miR-135b-5p promotes cisplatin resistance in gastric cancer JO - FASEB J. VL - 33 UR - https://doi.org/10.1096/fj.201701456RR DO - 10.1096/fj.201701456RR ID - Shao2019 ER - TY - JOUR AU - Zhou, J. AU - Chen, Q. PY - 2019 DA - 2019// TI - Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway JO - FASEB J. VL - 33 UR - https://doi.org/10.1096/fj.201800618RRR DO - 10.1096/fj.201800618RRR ID - Zhou2019 ER - TY - JOUR AU - Wang, Z. AU - Ji, F. PY - 2018 DA - 2018// TI - Downregulation of microRNA-17-5p inhibits drug resistance of gastric cancer cells partially through targeting p21 JO - Oncol Lett. VL - 15 ID - Wang2018 ER - TY - JOUR AU - Yan, R. AU - Li, K. AU - Yuan, D. W. AU - Wang, H. N. AU - Zhang, Y. AU - Dang, C. X. PY - 2018 DA - 2018// TI - Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1 JO - Int J Oncol. VL - 53 ID - Yan2018 ER - TY - JOUR AU - Li, B. AU - Wang, L. AU - Li, Z. AU - Wang, W. AU - Zhi, X. AU - Huang, X. PY - 2017 DA - 2017// TI - miR-3174 Contributes to Apoptosis and Autophagic Cell Death Defects in Gastric Cancer Cells by Targeting ARHGAP10 JO - Mol Ther Nucleic Acids. VL - 9 UR - https://doi.org/10.1016/j.omtn.2017.10.008 DO - 10.1016/j.omtn.2017.10.008 ID - Li2017 ER - TY - JOUR AU - Zhao, Q. AU - Li, Y. AU - Tan, B. B. AU - Fan, L. Q. AU - Yang, P. G. AU - Tian, Y. PY - 2015 DA - 2015// TI - HIF-1alpha Induces Multidrug Resistance in Gastric Cancer Cells by Inducing MiR-27a JO - PLoS One. VL - 10 UR - https://doi.org/10.1371/journal.pone.0132746 DO - 10.1371/journal.pone.0132746 ID - Zhao2015 ER - TY - JOUR AU - Yan, L. H. AU - Chen, Z. N. AU - Li, L. AU - Chen, J. AU - Wei, W. E. AU - Mo, X. W. PY - 2016 DA - 2016// TI - miR-135a promotes gastric cancer progression and resistance to oxaliplatin JO - Oncotarget. VL - 7 ID - Yan2016 ER - TY - JOUR AU - Lu, C. AU - Shan, Z. AU - Li, C. AU - Yang, L. PY - 2017 DA - 2017// TI - MiR-129 regulates cisplatin-resistance in human gastric cancer cells by targeting P-gp JO - Biomed Pharmacother. VL - 86 UR - https://doi.org/10.1016/j.biopha.2016.11.139 DO - 10.1016/j.biopha.2016.11.139 ID - Lu2017 ER - TY - JOUR AU - Hu, J. AU - Fang, Y. AU - Cao, Y. AU - Qin, R. AU - Chen, Q. PY - 2014 DA - 2014// TI - miR-449a Regulates proliferation and chemosensitivity to cisplatin by targeting cyclin D1 and BCL2 in SGC7901 cells JO - Dig Dis Sci. VL - 59 UR - https://doi.org/10.1007/s10620-013-2923-3 DO - 10.1007/s10620-013-2923-3 ID - Hu2014 ER - TY - JOUR AU - Yang, M. AU - Shan, X. AU - Zhou, X. AU - Qiu, T. AU - Zhu, W. AU - Ding, Y. PY - 2014 DA - 2014// TI - miR-1271 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and BCL2 JO - Anticancer Agents Med Chem. VL - 14 UR - https://doi.org/10.2174/1871520614666140528161318 DO - 10.2174/1871520614666140528161318 ID - Yang2014 ER - TY - JOUR AU - Zhuang, M. AU - Shi, Q. AU - Zhang, X. AU - Ding, Y. AU - Shan, L. AU - Shan, X. PY - 2015 DA - 2015// TI - Involvement of miR-143 in cisplatin resistance of gastric cancer cells via targeting IGF1R and BCL2 JO - Tumour Biol. VL - 36 UR - https://doi.org/10.1007/s13277-014-2898-5 DO - 10.1007/s13277-014-2898-5 ID - Zhuang2015 ER - TY - JOUR AU - Wang, T. AU - Ge, G. AU - Ding, Y. AU - Zhou, X. AU - Huang, Z. AU - Zhu, W. PY - 2014 DA - 2014// TI - MiR-503 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R and BCL2 JO - Chin Med J (Engl). VL - 127 ID - Wang2014 ER - TY - JOUR AU - An, Y. AU - Zhang, Z. AU - Shang, Y. AU - Jiang, X. AU - Dong, J. AU - Yu, P. PY - 2015 DA - 2015// TI - miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2 JO - Cell Death Dis VL - 6 UR - https://doi.org/10.1038/cddis.2015.123 DO - 10.1038/cddis.2015.123 ID - An2015 ER - TY - JOUR AU - Zhao, J. AU - Nie, Y. AU - Wang, H. AU - Lin, Y. PY - 2016 DA - 2016// TI - MiR-181a suppresses autophagy and sensitizes gastric cancer cells to cisplatin JO - Gene. VL - 576 UR - https://doi.org/10.1016/j.gene.2015.11.013 DO - 10.1016/j.gene.2015.11.013 ID - Zhao2016 ER - TY - JOUR AU - Du, X. AU - Liu, B. AU - Luan, X. AU - Cui, Q. AU - Li, L. PY - 2018 DA - 2018// TI - miR-30 decreases multidrug resistance in human gastric cancer cells by modulating cell autophagy JO - Exp Ther Med. VL - 15 ID - Du2018 ER - TY - JOUR AU - Li, B. AU - Wang, W. AU - Li, Z. AU - Chen, Z. AU - Zhi, X. AU - Xu, J. PY - 2017 DA - 2017// TI - MicroRNA-148a-3p enhances cisplatin cytotoxicity in gastric cancer through mitochondrial fission induction and cyto-protective autophagy suppression JO - Cancer Lett. VL - 410 UR - https://doi.org/10.1016/j.canlet.2017.09.035 DO - 10.1016/j.canlet.2017.09.035 ID - Li2017 ER - TY - JOUR AU - Chang, L. AU - Guo, F. AU - Wang, Y. AU - Lv, Y. AU - Huo, B. AU - Wang, L. PY - 2014 DA - 2014// TI - MicroRNA-200c regulates the sensitivity of chemotherapy of gastric cancer SGC7901/DDP cells by directly targeting RhoE JO - Pathol Oncol Res. VL - 20 UR - https://doi.org/10.1007/s12253-013-9664-7 DO - 10.1007/s12253-013-9664-7 ID - Chang2014 ER - TY - JOUR AU - Jiang, T. AU - Dong, P. AU - Li, L. AU - Ma, X. AU - Xu, P. AU - Zhu, H. PY - 2017 DA - 2017// TI - MicroRNA-200c regulates cisplatin resistance by targeting ZEB2 in human gastric cancer cells JO - Oncol Rep. VL - 38 UR - https://doi.org/10.3892/or.2017.5659 DO - 10.3892/or.2017.5659 ID - Jiang2017 ER - TY - JOUR AU - Bao, J. AU - Xu, Y. AU - Wang, Q. AU - Zhang, J. AU - Li, Z. AU - Li, D. PY - 2017 DA - 2017// TI - miR-101 alleviates chemoresistance of gastric cancer cells by targeting ANXA2 JO - Biomed Pharmacother VL - 92 UR - https://doi.org/10.1016/j.biopha.2017.06.011 DO - 10.1016/j.biopha.2017.06.011 ID - Bao2017 ER - TY - JOUR AU - Li, G. AU - Yang, F. AU - Gu, S. AU - Li, Z. AU - Xue, M. PY - 2016 DA - 2016// TI - MicroRNA-101 induces apoptosis in cisplatin-resistant gastric cancer cells by targeting VEGF-C JO - Mol Med Rep. VL - 13 UR - https://doi.org/10.3892/mmr.2015.4560 DO - 10.3892/mmr.2015.4560 ID - Li2016 ER - TY - JOUR AU - Zhang, X. L. AU - Shi, H. J. AU - Wang, J. P. AU - Tang, H. S. AU - Wu, Y. B. AU - Fang, Z. Y. PY - 2014 DA - 2014// TI - MicroRNA-218 is upregulated in gastric cancer after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and increases chemosensitivity to cisplatin JO - World J Gastroenterol. VL - 20 UR - https://doi.org/10.3748/wjg.v20.i32.11347 DO - 10.3748/wjg.v20.i32.11347 ID - Zhang2014 ER - TY - JOUR AU - Zhang, Z. AU - Kong, Y. AU - Yang, W. AU - Ma, F. AU - Zhang, Y. AU - Ji, S. PY - 2016 DA - 2016// TI - Upregulation of microRNA-34a enhances the DDP sensitivity of gastric cancer cells by modulating proliferation and apoptosis via targeting MET JO - Oncol Rep. VL - 36 UR - https://doi.org/10.3892/or.2016.5016 DO - 10.3892/or.2016.5016 ID - Zhang2016 ER - TY - JOUR AU - Wen, L. AU - Cheng, F. AU - Zhou, Y. AU - Yin, C. PY - 2015 DA - 2015// TI - MiR-26a enhances the sensitivity of gastric cancer cells to cisplatin by targeting NRAS and E2F2 JO - Saudi J Gastroenterol. VL - 21 UR - https://doi.org/10.4103/1319-3767.166206 DO - 10.4103/1319-3767.166206 ID - Wen2015 ER - TY - JOUR AU - Li, X. AU - Liang, J. AU - Liu, Y. X. AU - Wang, Y. AU - Yang, X. H. AU - Luan, B. H. PY - 2016 DA - 2016// TI - miR-149 reverses cisplatin resistance of gastric cancer SGC7901/DDP cells by targeting FoxM1 JO - Pharmazie. VL - 71 ID - Li2016 ER - TY - JOUR AU - Wang, J. AU - Xue, X. AU - Hong, H. AU - Qin, M. AU - Zhou, J. AU - Sun, Q. PY - 2017 DA - 2017// TI - Upregulation of microRNA-524-5p enhances the cisplatin sensitivity of gastric cancer cells by modulating proliferation and metastasis via targeting SOX9 JO - Oncotarget. VL - 8 ID - Wang2017 ER - TY - JOUR AU - Wei, X. AU - Gao, M. AU - Ahmed, Y. AU - Gao, M. AU - Liu, W. AU - Zhang, Y. PY - 2019 DA - 2019// TI - MicroRNA-362-5p enhances the cisplatin sensitivity of gastric cancer cells by targeting suppressor of zeste 12 protein JO - Oncol Lett. VL - 18 ID - Wei2019 ER - TY - STD TI - Gu J, Li X, Li H, Jin Z, Jin J. MicroRNA-198 inhibits proliferation and induces apoptosis by directly suppressing FGFR1 in gastric cancer. Biosci Rep. 2019;39(6):BSR20181258. ID - ref118 ER - TY - JOUR AU - Wang, M. AU - Zhang, R. AU - Zhang, S. AU - Xu, R. AU - Yang, Q. PY - 2019 DA - 2019// TI - MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells JO - Gene. VL - 700 UR - https://doi.org/10.1016/j.gene.2019.03.043 DO - 10.1016/j.gene.2019.03.043 ID - Wang2019 ER - TY - JOUR AU - Peng, C. AU - Huang, K. AU - Liu, G. AU - Li, Y. AU - Yu, C. PY - 2019 DA - 2019// TI - MiR-876-3p regulates cisplatin resistance and stem cell-like properties of gastric cancer cells by targeting TMED3 JO - J Gastroenterol Hepatol. VL - 34 UR - https://doi.org/10.1111/jgh.14649 DO - 10.1111/jgh.14649 ID - Peng2019 ER - TY - JOUR AU - Huang, H. AU - Tang, J. AU - Zhang, L. AU - Bu, Y. AU - Zhang, X. PY - 2018 DA - 2018// TI - miR-874 regulates multiple-drug resistance in gastric cancer by targeting ATG16L1 JO - Int J Oncol. VL - 53 ID - Huang2018 ER - TY - JOUR AU - Han, X. AU - Zhang, J. J. AU - Han, Z. Q. AU - Zhang, H. B. AU - Wang, Z. A. PY - 2018 DA - 2018// TI - Let-7b attenuates cisplatin resistance and tumor growth in gastric cancer by targeting AURKB JO - Cancer Gene Ther. VL - 25 UR - https://doi.org/10.1038/s41417-018-0048-8 DO - 10.1038/s41417-018-0048-8 ID - Han2018 ER - TY - JOUR AU - Song, A. L. AU - Zhao, L. AU - Wang, Y. W. AU - He, D. Q. AU - Li, Y. M. PY - 2019 DA - 2019// TI - Chemoresistance in gastric cancer is attributed to the overexpression of excision repair cross-complementing 1 (ERCC1) caused by microRNA-122 dysregulation JO - J Cell Physiol. VL - 234 UR - https://doi.org/10.1002/jcp.28812 DO - 10.1002/jcp.28812 ID - Song2019 ER - TY - JOUR AU - Xie, X. AU - Huang, N. AU - Zhang, Y. AU - Wei, X. AU - Gao, M. AU - Li, M. PY - 2019 DA - 2019// TI - MiR-192-5p reverses cisplatin resistance by targeting ERCC3 and ERCC4 in SGC7901/DDP cells JO - J Cancer. VL - 10 UR - https://doi.org/10.7150/jca.25814 DO - 10.7150/jca.25814 ID - Xie2019 ER - TY - JOUR AU - Longley, D. B. AU - Harkin, D. P. AU - Johnston, P. G. PY - 2003 DA - 2003// TI - 5-fluorouracil: mechanisms of action and clinical strategies JO - Nat Rev Cancer. VL - 3 UR - https://doi.org/10.1038/nrc1074 DO - 10.1038/nrc1074 ID - Longley2003 ER - TY - JOUR AU - Noordhuis, P. AU - Holwerda, U. AU - Wilt, C. L. AU - Groeningen, C. J. AU - Smid, K. AU - Meijer, S. PY - 2004 DA - 2004// TI - 5-Fluorouracil incorporation into RNA and DNA in relation to thymidylate synthase inhibition of human colorectal cancers JO - Ann Oncol. VL - 15 UR - https://doi.org/10.1093/annonc/mdh264 DO - 10.1093/annonc/mdh264 ID - Noordhuis2004 ER - TY - JOUR AU - Jian, B. AU - Li, Z. AU - Xiao, D. AU - He, G. AU - Bai, L. AU - Yang, Q. PY - 2016 DA - 2016// TI - Downregulation of microRNA-193-3p inhibits tumor proliferation migration and chemoresistance in human gastric cancer by regulating PTEN gene JO - Tumour Biol. VL - 37 UR - https://doi.org/10.1007/s13277-015-4727-x DO - 10.1007/s13277-015-4727-x ID - Jian2016 ER - TY - JOUR AU - Shen, J. AU - Niu, W. AU - Zhang, H. AU - Jun, M. AU - Zhang, H. PY - 2018 DA - 2018// TI - Downregulation of MicroRNA-147 Inhibits Cell Proliferation and Increases the Chemosensitivity of Gastric Cancer Cells to 5-Fluorouracil by Directly Targeting PTEN JO - Oncol Res. VL - 26 UR - https://doi.org/10.3727/096504017X15061902533715 DO - 10.3727/096504017X15061902533715 ID - Shen2018 ER - TY - JOUR AU - Wu, D. M. AU - Hong, X. W. AU - Wang, L. L. AU - Cui, X. F. AU - Lu, J. AU - Chen, G. Q. PY - 2018 DA - 2018// TI - MicroRNA-17 inhibition overcomes chemoresistance and suppresses epithelial-mesenchymal transition through a DEDD-dependent mechanism in gastric cancer JO - Int J Biochem Cell Biol. VL - 102 UR - https://doi.org/10.1016/j.biocel.2018.06.007 DO - 10.1016/j.biocel.2018.06.007 ID - Wu2018 ER - TY - JOUR AU - Zhu, P. AU - Zhang, J. AU - Zhu, J. AU - Shi, J. AU - Zhu, Q. AU - Gao, Y. PY - 2015 DA - 2015// TI - MiR-429 Induces Gastric Carcinoma Cell Apoptosis Through Bcl-2 JO - Cell Physiol Biochem. VL - 37 UR - https://doi.org/10.1159/000438524 DO - 10.1159/000438524 ID - Zhu2015 ER - TY - JOUR AU - Korourian, A. AU - Roudi, R. AU - Shariftabrizi, A. AU - Madjd, Z. PY - 2017 DA - 2017// TI - MicroRNA-31 inhibits RhoA-mediated tumor invasion and chemotherapy resistance in MKN-45 gastric adenocarcinoma cells JO - Exp Biol Med (Maywood). VL - 242 UR - https://doi.org/10.1177/1535370217728460 DO - 10.1177/1535370217728460 ID - Korourian2017 ER - TY - JOUR AU - Sun, K. K. AU - Shen, X. J. AU - Yang, D. AU - Gan, M. Q. AU - Liu, G. AU - Zhang, Y. F. PY - 2019 DA - 2019// TI - MicroRNA-31 triggers G2/M cell cycle arrest, enhances the chemosensitivity and inhibits migration and invasion of human gastric cancer cells by downregulating the expression of zeste homolog 2 (ZH2) JO - Arch Biochem Biophys. VL - 663 UR - https://doi.org/10.1016/j.abb.2019.01.023 DO - 10.1016/j.abb.2019.01.023 ID - Sun2019 ER - TY - JOUR AU - Korourian, A. AU - Madjd, Z. AU - Roudi, R. AU - Shariftabrizi, A. AU - Soleimani, M. PY - 2019 DA - 2019// TI - Induction of miR-31 causes increased sensitivity to 5-FU and decreased migration and cell invasion in gastric adenocarcinoma JO - Bratisl Lek Listy. VL - 120 ID - Korourian2019 ER - TY - JOUR AU - Xiong, H. L. AU - Zhou, S. W. AU - Sun, A. H. AU - He, Y. AU - Li, J. AU - Yuan, X. PY - 2015 DA - 2015// TI - MicroRNA197 reverses the drug resistance of fluorouracilinduced SGC7901 cells by targeting mitogenactivated protein kinase 1 JO - Mol Med Rep. VL - 12 UR - https://doi.org/10.3892/mmr.2015.4052 DO - 10.3892/mmr.2015.4052 ID - Xiong2015 ER - TY - JOUR AU - Choi, H. AU - Lee, S. K. PY - 2017 DA - 2017// TI - TAX1BP1 downregulation by EBV-miR-BART15-3p enhances chemosensitivity of gastric cancer cells to 5-FU JO - Arch Virol. VL - 162 UR - https://doi.org/10.1007/s00705-016-3109-z DO - 10.1007/s00705-016-3109-z ID - Choi2017 ER - TY - JOUR AU - Nie, H. AU - Mu, J. AU - Wang, J. AU - Li, Y. PY - 2018 DA - 2018// TI - miR1955p regulates multidrug resistance of gastric cancer cells via targeting ZNF139 JO - Oncol Rep. VL - 40 ID - Nie2018 ER - TY - JOUR AU - Li, L. Q. AU - Pan, D. AU - Chen, Q. AU - Zhang, S. W. AU - Xie, D. Y. AU - Zheng, X. L. PY - 2018 DA - 2018// TI - Sensitization of Gastric Cancer Cells to 5-FU by MicroRNA-204 Through Targeting the TGFBR2-Mediated Epithelial to Mesenchymal Transition JO - Cell Physiol Biochem. VL - 47 UR - https://doi.org/10.1159/000490871 DO - 10.1159/000490871 ID - Li2018 ER - TY - JOUR AU - Jiang, L. AU - Yang, W. AU - Bian, W. AU - Yang, H. AU - Wu, X. AU - Li, Y. PY - 2018 DA - 2018// TI - MicroRNA-623 Targets Cyclin D1 to Inhibit Cell Proliferation and Enhance the Chemosensitivity of Cells to 5-Fluorouracil in Gastric Cancer JO - Oncol Res. VL - 27 UR - https://doi.org/10.3727/096504018X15193469240508 DO - 10.3727/096504018X15193469240508 ID - Jiang2018 ER - TY - JOUR AU - Zhang, J. X. AU - Xu, Y. AU - Gao, Y. AU - Chen, C. AU - Zheng, Z. S. AU - Yun, M. PY - 2017 DA - 2017// TI - Decreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathway JO - Mol Cancer. VL - 16 UR - https://doi.org/10.1186/s12943-017-0586-y DO - 10.1186/s12943-017-0586-y ID - Zhang2017 ER - TY - JOUR AU - Xie, L. AU - Zhang, Z. AU - Tan, Z. AU - He, R. AU - Zeng, X. AU - Xie, Y. PY - 2014 DA - 2014// TI - MicroRNA-124 inhibits proliferation and induces apoptosis by directly repressing EZH2 in gastric cancer JO - Mol Cell Biochem. VL - 392 UR - https://doi.org/10.1007/s11010-014-2028-0 DO - 10.1007/s11010-014-2028-0 ID - Xie2014 ER - TY - JOUR AU - Cao, W. AU - Wei, W. AU - Zhan, Z. AU - Xie, D. AU - Xie, Y. AU - Xiao, Q. PY - 2018 DA - 2018// TI - Regulation of drug resistance and metastasis of gastric cancer cells via the microRNA647-ANK2 axis JO - Int J Mol Med. VL - 41 ID - Cao2018 ER - TY - JOUR AU - Cao, W. AU - Wei, W. AU - Zhan, Z. AU - Xie, Y. AU - Xiao, Q. PY - 2016 DA - 2016// TI - MiR-1284 modulates multidrug resistance of gastric cancer cells by targeting EIF4A1 JO - Oncol Rep. VL - 35 UR - https://doi.org/10.3892/or.2016.4643 DO - 10.3892/or.2016.4643 ID - Cao2016 ER - TY - JOUR AU - Jin, B. AU - Liu, Y. AU - Wang, H. PY - 2015 DA - 2015// TI - Antagonism of miRNA-21 Sensitizes Human Gastric Cancer Cells to Paclitaxel JO - Cell Biochem Biophys. VL - 72 UR - https://doi.org/10.1007/s12013-014-0450-2 DO - 10.1007/s12013-014-0450-2 ID - Jin2015 ER - TY - JOUR AU - Liu, X. AU - Ru, J. AU - Zhang, J. AU - Zhu, L. H. AU - Liu, M. AU - Li, X. PY - 2013 DA - 2013// TI - miR-23a targets interferon regulatory factor 1 and modulates cellular proliferation and paclitaxel-induced apoptosis in gastric adenocarcinoma cells JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0064707 DO - 10.1371/journal.pone.0064707 ID - Liu2013 ER - TY - JOUR AU - Shen, B. AU - Yu, S. AU - Zhang, Y. AU - Yuan, Y. AU - Li, X. AU - Zhong, J. PY - 2016 DA - 2016// TI - miR-590-5p regulates gastric cancer cell growth and chemosensitivity through RECK and the AKT/ERK pathway JO - Onco Targets Ther. VL - 9 UR - https://doi.org/10.2147/OTT.S110923 DO - 10.2147/OTT.S110923 ID - Shen2016 ER - TY - JOUR AU - Wang, M. AU - Qiu, R. AU - Yu, S. AU - Xu, X. AU - Li, G. AU - Gu, R. PY - 2019 DA - 2019// TI - Paclitaxelresistant gastric cancer MGC803 cells promote epithelialtomesenchymal transition and chemoresistance in paclitaxelsensitive cells via exosomal delivery of miR1555p JO - Int J Oncol. VL - 54 ID - Wang2019 ER - TY - JOUR AU - Wu, H. AU - Huang, M. AU - Lu, M. AU - Zhu, W. AU - Shu, Y. AU - Cao, P. PY - 2013 DA - 2013// TI - Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel JO - Cancer Chemother Pharmacol. VL - 71 UR - https://doi.org/10.1007/s00280-013-2108-y DO - 10.1007/s00280-013-2108-y ID - Wu2013 ER - TY - JOUR AU - Li, L. AU - Wu, C. AU - Zhao, Y. PY - 2017 DA - 2017// TI - miRNA-34a enhances the sensitivity of gastric cancer cells to treatment with paclitaxel by targeting E2F5 JO - Oncol Lett. VL - 13 UR - https://doi.org/10.3892/ol.2017.6041 DO - 10.3892/ol.2017.6041 ID - Li2017 ER - TY - JOUR AU - Zou, Z. AU - Zou, R. AU - Zong, D. AU - Shi, Y. AU - Chen, J. AU - Huang, J. PY - 2017 DA - 2017// TI - miR-495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression JO - J Cell Mol Med. VL - 21 UR - https://doi.org/10.1111/jcmm.13114 DO - 10.1111/jcmm.13114 ID - Zou2017 ER - TY - JOUR AU - Bang, Y. J. AU - Cutsem, E. AU - Feyereislova, A. AU - Chung, H. C. AU - Shen, L. AU - Sawaki, A. PY - 2010 DA - 2010// TI - Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial JO - Lancet. VL - 376 UR - https://doi.org/10.1016/S0140-6736(10)61121-X DO - 10.1016/S0140-6736(10)61121-X ID - Bang2010 ER - TY - JOUR AU - Fuchs, C. S. AU - Tomasek, J. AU - Yong, C. J. AU - Dumitru, F. AU - Passalacqua, R. AU - Goswami, C. PY - 2014 DA - 2014// TI - Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial JO - Lancet. VL - 383 UR - https://doi.org/10.1016/S0140-6736(13)61719-5 DO - 10.1016/S0140-6736(13)61719-5 ID - Fuchs2014 ER - TY - JOUR AU - Wilke, H. AU - Muro, K. AU - Cutsem, E. AU - Oh, S. C. AU - Bodoky, G. AU - Shimada, Y. PY - 2014 DA - 2014// TI - Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial JO - Lancet Oncol. VL - 15 UR - https://doi.org/10.1016/S1470-2045(14)70420-6 DO - 10.1016/S1470-2045(14)70420-6 ID - Wilke2014 ER - TY - JOUR AU - Kang, Y. K. AU - Boku, N. AU - Satoh, T. AU - Ryu, M. H. AU - Chao, Y. AU - Kato, K. PY - 2017 DA - 2017// TI - Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial JO - Lancet. VL - 390 UR - https://doi.org/10.1016/S0140-6736(17)31827-5 DO - 10.1016/S0140-6736(17)31827-5 ID - Kang2017 ER - TY - JOUR AU - Eto, K. AU - Iwatsuki, M. AU - Watanabe, M. AU - Ida, S. AU - Ishimoto, T. AU - Iwagami, S. PY - 2014 DA - 2014// TI - The microRNA-21/PTEN pathway regulates the sensitivity of HER2-positive gastric cancer cells to trastuzumab JO - Ann Surg Oncol. VL - 21 UR - https://doi.org/10.1245/s10434-013-3325-7 DO - 10.1245/s10434-013-3325-7 ID - Eto2014 ER - TY - JOUR AU - Sui, M. AU - Jiao, A. AU - Zhai, H. AU - Wang, Y. AU - Wang, Y. AU - Sun, D. PY - 2017 DA - 2017// TI - Upregulation of miR-125b is associated with poor prognosis and trastuzumab resistance in HER2-positive gastric cancer JO - Exp Ther Med. VL - 14 UR - https://doi.org/10.3892/etm.2017.4548 DO - 10.3892/etm.2017.4548 ID - Sui2017 ER - TY - JOUR AU - Eto, K. AU - Iwatsuki, M. AU - Watanabe, M. AU - Ishimoto, T. AU - Ida, S. AU - Imamura, Y. PY - 2015 DA - 2015// TI - The sensitivity of gastric cancer to trastuzumab is regulated by the miR-223/FBXW7 pathway JO - Int J Cancer. VL - 136 UR - https://doi.org/10.1002/ijc.29168 DO - 10.1002/ijc.29168 ID - Eto2015 ER - TY - JOUR AU - Zhou, X. AU - Men, X. AU - Zhao, R. AU - Han, J. AU - Fan, Z. AU - Wang, Y. PY - 2018 DA - 2018// TI - miR-200c inhibits TGF-beta-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer JO - Cancer Gene Ther. VL - 25 UR - https://doi.org/10.1038/s41417-017-0005-y DO - 10.1038/s41417-017-0005-y ID - Zhou2018 ER - TY - JOUR AU - Venturutti, L. AU - Cordo Russo, R. I. AU - Rivas, M. A. AU - Mercogliano, M. F. AU - Izzo, F. AU - Oakley, R. H. PY - 2016 DA - 2016// TI - MiR-16 mediates trastuzumab and lapatinib response in ErbB-2-positive breast and gastric cancer via its novel targets CCNJ and FUBP1 JO - Oncogene. VL - 35 UR - https://doi.org/10.1038/onc.2016.151 DO - 10.1038/onc.2016.151 ID - Venturutti2016 ER - TY - JOUR AU - Yu, Y. AU - Yu, X. AU - Liu, H. AU - Song, Q. AU - Yang, Y. PY - 2018 DA - 2018// TI - miR494 inhibits cancerinitiating cell phenotypes and reverses resistance to lapatinib by downregulating FGFR2 in HER2positive gastric cancer JO - Int J Mol Med. VL - 42 ID - Yu2018 ER - TY - JOUR AU - Fan, B. AU - Shen, C. AU - Wu, M. AU - Zhao, J. AU - Guo, Q. AU - Luo, Y. PY - 2018 DA - 2018// TI - miR-17-92 cluster is connected with disease progression and oxaliplatin/capecitabine chemotherapy efficacy in advanced gastric cancer patients: A preliminary study JO - Medicine (Baltimore) VL - 97 UR - https://doi.org/10.1097/MD.0000000000012007 DO - 10.1097/MD.0000000000012007 ID - Fan2018 ER - TY - JOUR AU - Li, H. AU - Ma, X. AU - Yang, D. AU - Suo, Z. AU - Dai, R. AU - Liu, C. PY - 2020 DA - 2020// TI - PCAT-1 contributes to cisplatin resistance in gastric cancer through epigenetically silencing PTEN via recruiting EZH2 JO - J Cell Biochem. VL - 121 UR - https://doi.org/10.1002/jcb.29370 DO - 10.1002/jcb.29370 ID - Li2020 ER - TY - JOUR AU - Guo, Y. AU - Yue, P. AU - Wang, Y. AU - Chen, G. AU - Li, Y. PY - 2019 DA - 2019// TI - PCAT-1 contributes to cisplatin resistance in gastric cancer through miR-128/ZEB1 axis JO - Biomed Pharmacother. VL - 118 UR - https://doi.org/10.1016/j.biopha.2019.109255 DO - 10.1016/j.biopha.2019.109255 ID - Guo2019 ER - TY - JOUR AU - Xu, Y. D. AU - Shang, J. AU - Li, M. AU - Zhang, Y. Y. PY - 2019 DA - 2019// TI - LncRNA DANCR accelerates the development of multidrug resistance of gastric cancer JO - Eur Rev Med Pharmacol Sci. VL - 23 ID - Xu2019 ER - TY - JOUR AU - Li, M. AU - Zhang, Y. Y. AU - Shang, J. AU - Xu, Y. D. PY - 2019 DA - 2019// TI - LncRNA SNHG5 promotes cisplatin resistance in gastric cancer via inhibiting cell apoptosis JO - Eur Rev Med Pharmacol Sci. VL - 23 ID - Li2019 ER - TY - JOUR AU - Zhang, X. AU - Bo, P. AU - Liu, L. AU - Zhang, X. AU - Li, J. PY - 2017 DA - 2017// TI - Overexpression of long non-coding RNA GHET1 promotes the development of multidrug resistance in gastric cancer cells JO - Biomed Pharmacother. VL - 92 UR - https://doi.org/10.1016/j.biopha.2017.04.111 DO - 10.1016/j.biopha.2017.04.111 ID - Zhang2017 ER - TY - JOUR AU - Hang, Q. AU - Sun, R. AU - Jiang, C. AU - Li, Y. PY - 2015 DA - 2015// TI - Notch 1 promotes cisplatin-resistant gastric cancer formation by upregulating lncRNA AK022798 expression JO - Anticancer Drugs. VL - 26 ID - Hang2015 ER - TY - JOUR AU - Lan, W. G. AU - Xu, D. H. AU - Xu, C. AU - Ding, C. L. AU - Ning, F. L. AU - Zhou, Y. L. PY - 2016 DA - 2016// TI - Silencing of long non-coding RNA ANRIL inhibits the development of multidrug resistance in gastric cancer cells JO - Oncol Rep. VL - 36 UR - https://doi.org/10.3892/or.2016.4771 DO - 10.3892/or.2016.4771 ID - Lan2016 ER - TY - JOUR AU - Fang, Q. AU - Chen, X. AU - Zhi, X. PY - 2016 DA - 2016// TI - Long Non-Coding RNA (LncRNA) Urothelial Carcinoma Associated 1 (UCA1) Increases Multi-Drug Resistance of Gastric Cancer via Downregulating miR-27b JO - Med Sci Monit. VL - 22 UR - https://doi.org/10.12659/MSM.900688 DO - 10.12659/MSM.900688 ID - Fang2016 ER - TY - JOUR AU - Zhang, Y. AU - Song, X. AU - Wang, X. AU - Hu, J. AU - Jiang, L. PY - 2016 DA - 2016// TI - Silencing of LncRNA HULC Enhances Chemotherapy Induced Apoptosis in Human Gastric Cancer JO - J Med Biochem. VL - 35 UR - https://doi.org/10.1515/jomb-2015-0016 DO - 10.1515/jomb-2015-0016 ID - Zhang2016 ER - TY - JOUR AU - Yan, J. i. n. AU - Dang, Y. i. n. i. AU - Liu, S. h. i. y. u. AU - Zhang, Y. i. f. e. n. g. AU - Zhang, G. u. o. x. i. n. PY - 2016 DA - 2016// TI - LncRNA HOTAIR promotes cisplatin resistance in gastric cancer by targeting miR-126 to activate the PI3K/AKT/MRP1 genes JO - Tumor Biology VL - 37 UR - https://doi.org/10.1007/s13277-016-5448-5 DO - 10.1007/s13277-016-5448-5 ID - Yan2016 ER - TY - JOUR AU - Cheng, C. AU - Qin, Y. AU - Zhi, Q. AU - Wang, J. AU - Qin, C. PY - 2018 DA - 2018// TI - Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/beta-catenin signaling pathways by up-regulating miR-34a JO - Int J Biol Macromol VL - 107 UR - https://doi.org/10.1016/j.ijbiomac.2017.10.154 DO - 10.1016/j.ijbiomac.2017.10.154 ID - Cheng2018 ER - TY - JOUR AU - Zeng, L. AU - Liao, Q. AU - Zou, Z. AU - Wen, Y. AU - Wang, J. AU - Liu, C. PY - 2018 DA - 2018// TI - Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway JO - Cell Physiol Biochem. VL - 51 UR - https://doi.org/10.1159/000495499 DO - 10.1159/000495499 ID - Zeng2018 ER - TY - JOUR AU - Xu, W. AU - He, L. AU - Li, Y. AU - Tan, Y. AU - Zhang, F. AU - Xu, H. PY - 2018 DA - 2018// TI - Silencing of lncRNA ZFAS1 inhibits malignancies by blocking Wnt/beta-catenin signaling in gastric cancer cells JO - Biosci Biotechnol Biochem. VL - 82 UR - https://doi.org/10.1080/09168451.2018.1431518 DO - 10.1080/09168451.2018.1431518 ID - Xu2018 ER - TY - JOUR AU - Wang, L. AU - Chunyan, Q. AU - Zhou, Y. AU - He, Q. AU - Ma, Y. AU - Ga, Y. PY - 2017 DA - 2017// TI - BCAR4 increase cisplatin resistance and predicted poor survival in gastric cancer patients JO - Eur Rev Med Pharmacol Sci. VL - 21 ID - Wang2017 ER - TY - JOUR AU - YiRen, H. AU - YingCong, Y. AU - Sunwu, Y. AU - Keqin, L. AU - Xiaochun, T. AU - Senrui, C. PY - 2017 DA - 2017// TI - Long noncoding RNA MALAT1 regulates autophagy associated chemoresistance via miR-23b-3p sequestration in gastric cancer JO - Mol Cancer. VL - 16 UR - https://doi.org/10.1186/s12943-017-0743-3 DO - 10.1186/s12943-017-0743-3 ID - YiRen2017 ER - TY - JOUR AU - Zhang, X. W. AU - Bu, P. AU - Liu, L. AU - Zhang, X. Z. AU - Li, J. PY - 2015 DA - 2015// TI - Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance JO - Biochem Biophys Res Commun. VL - 462 UR - https://doi.org/10.1016/j.bbrc.2015.04.121 DO - 10.1016/j.bbrc.2015.04.121 ID - Zhang2015 ER - TY - JOUR AU - Ding, J. AU - Li, D. AU - Gong, M. AU - Wang, J. AU - Huang, X. AU - Wu, T. PY - 2014 DA - 2014// TI - Expression and clinical significance of the long non-coding RNA PVT1 in human gastric cancer JO - Onco Targets Ther. VL - 7 UR - https://doi.org/10.2147/OTT.S68854 DO - 10.2147/OTT.S68854 ID - Ding2014 ER - TY - JOUR AU - Du, P. AU - Hu, C. AU - Qin, Y. AU - Zhao, J. AU - Patel, R. AU - Fu, Y. PY - 2019 DA - 2019// TI - LncRNA PVT1 Mediates Antiapoptosis and 5-Fluorouracil Resistance via Increasing Bcl2 Expression in Gastric Cancer JO - J Oncol. VL - 2019 UR - https://doi.org/10.1155/2019/9325407 DO - 10.1155/2019/9325407 ID - Du2019 ER - TY - JOUR AU - Wu, X. AU - Zheng, Y. AU - Han, B. AU - Dong, X. PY - 2018 DA - 2018// TI - Long noncoding RNA BLACAT1 modulates ABCB1 to promote oxaliplatin resistance of gastric cancer via sponging miR-361 JO - Biomed Pharmacother. VL - 99 UR - https://doi.org/10.1016/j.biopha.2018.01.130 DO - 10.1016/j.biopha.2018.01.130 ID - Wu2018 ER - TY - JOUR AU - Li, Y. AU - Lv, S. AU - Ning, H. AU - Li, K. AU - Zhou, X. AU - Xv, H. PY - 2018 DA - 2018// TI - Down-regulation of CASC2 contributes to cisplatin resistance in gastric cancer by sponging miR-19a JO - Biomed Pharmacother. VL - 108 UR - https://doi.org/10.1016/j.biopha.2018.09.181 DO - 10.1016/j.biopha.2018.09.181 ID - Li2018 ER - TY - STD TI - Wang Z, Wang Q, Xu G, Meng N, Huang X, Jiang Z, et al. The long noncoding RNA CRAL reverses cisplatin resistance via the miR-505/CYLD/AKT axis in human gastric cancer cells. RNA Biol. 2020:1–14. In press. ID - ref181 ER - TY - JOUR AU - Wang, H. AU - Qin, R. AU - Guan, A. AU - Yao, Y. AU - Huang, Y. AU - Jia, H. PY - 2018 DA - 2018// TI - HOTAIR enhanced paclitaxel and doxorubicin resistance in gastric cancer cells partly through inhibiting miR-217 expression JO - J Cell Biochem. VL - 119 UR - https://doi.org/10.1002/jcb.26901 DO - 10.1002/jcb.26901 ID - Wang2018 ER - TY - JOUR AU - Shang, C. AU - Sun, L. AU - Zhang, J. AU - Zhao, B. AU - Chen, X. AU - Xu, H. PY - 2017 DA - 2017// TI - Silence of cancer susceptibility candidate 9 inhibits gastric cancer and reverses chemoresistance JO - Oncotarget. VL - 8 UR - https://doi.org/10.18632/oncotarget.14871 DO - 10.18632/oncotarget.14871 ID - Shang2017 ER - TY - JOUR AU - Wang, Y. AU - Zhang, D. AU - Wu, K. AU - Zhao, Q. AU - Nie, Y. AU - Fan, D. PY - 2014 DA - 2014// TI - Long noncoding RNA MRUL promotes ABCB1 expression in multidrug-resistant gastric cancer cell sublines JO - Mol Cell Biol. VL - 34 UR - https://doi.org/10.1128/MCB.01580-13 DO - 10.1128/MCB.01580-13 ID - Wang2014 ER - TY - JOUR AU - Shang, C. AU - Guo, Y. AU - Zhang, J. AU - Huang, B. PY - 2016 DA - 2016// TI - Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer JO - Cancer Chemother Pharmacol. VL - 77 UR - https://doi.org/10.1007/s00280-016-3029-3 DO - 10.1007/s00280-016-3029-3 ID - Shang2016 ER - TY - JOUR AU - Zhou, Z. AU - Lin, Z. AU - He, Y. AU - Pang, X. AU - Wang, Y. AU - Ponnusamy, M. PY - 2018 DA - 2018// TI - The Long Noncoding RNA D63785 Regulates Chemotherapy Sensitivity in Human Gastric Cancer by Targeting miR-422a JO - Mol Ther Nucleic Acids. VL - 12 UR - https://doi.org/10.1016/j.omtn.2018.05.024 DO - 10.1016/j.omtn.2018.05.024 ID - Zhou2018 ER - TY - JOUR AU - Zhang, J. AU - Zhao, B. AU - Chen, X. AU - Wang, Z. AU - Xu, H. AU - Huang, B. PY - 2018 DA - 2018// TI - Silence of Long Noncoding RNA NEAT1 Inhibits Malignant Biological Behaviors and Chemotherapy Resistance in Gastric Cancer JO - Pathol Oncol Res. VL - 24 UR - https://doi.org/10.1007/s12253-017-0233-3 DO - 10.1007/s12253-017-0233-3 ID - Zhang2018 ER - TY - JOUR AU - Wang, S. AU - Chen, W. AU - Yu, H. AU - Song, Z. AU - Li, Q. AU - Shen, X. PY - 2020 DA - 2020// TI - lncRNA ROR Promotes Gastric Cancer Drug Resistance JO - Cancer Control VL - 27 UR - https://doi.org/10.1177/1073274820904694 DO - 10.1177/1073274820904694 ID - Wang2020 ER - TY - JOUR AU - Han, Y. AU - Ye, J. AU - Wu, D. AU - Wu, P. AU - Chen, Z. AU - Chen, J. PY - 2014 DA - 2014// TI - LEIGC long non-coding RNA acts as a tumor suppressor in gastric carcinoma by inhibiting the epithelial-to-mesenchymal transition JO - BMC Cancer. VL - 14 UR - https://doi.org/10.1186/1471-2407-14-932 DO - 10.1186/1471-2407-14-932 ID - Han2014 ER - TY - JOUR AU - Liu, W. G. AU - Xu, Q. PY - 2019 DA - 2019// TI - Upregulation of circHIPK3 promotes the progression of gastric cancer via Wnt/beta-catenin pathway and indicates a poor prognosis JO - Eur Rev Med Pharmacol Sci. VL - 23 ID - Liu2019 ER - TY - JOUR AU - Shen, Z. AU - Zhou, L. AU - Zhang, C. AU - Xu, J. PY - 2019 DA - 2019// TI - Reduction of circular RNA Foxo3 promotes prostate cancer progression and chemoresistance to docetaxel JO - Cancer Lett. VL - 468 UR - https://doi.org/10.1016/j.canlet.2019.10.006 DO - 10.1016/j.canlet.2019.10.006 ID - Shen2019 ER - TY - JOUR AU - Sun, Y. AU - Li, X. AU - Chen, A. AU - Shi, W. AU - Wang, L. AU - Yi, R. PY - 2019 DA - 2019// TI - circPIP5K1A serves as a competitive endogenous RNA contributing to ovarian cancer progression via regulation of miR-661/IGFBP5 signaling JO - J Cell Biochem VL - 120 UR - https://doi.org/10.1002/jcb.29055 DO - 10.1002/jcb.29055 ID - Sun2019 ER - TY - JOUR AU - Yu, J. i. a. n. AU - Ding, W. e. n. ‐. b. i. n. g. AU - Wang, M. e. n. g. ‐. c. h. a. o. AU - Guo, X. i. n. g. ‐. g. a. n. g. AU - Xu, J. i. a. n. AU - Xu, Q. i. n. g. ‐. g. u. o. AU - Yang, Y. u. a. n. AU - Sun, S. h. u. ‐. h. a. n. AU - Liu, J. i. n. g. ‐. f. e. n. g. AU - Qin, L. u. n. ‐. x. i. u. AU - Liu, H. u. i. AU - Yang, F. u. AU - Zhou, W. e. i. ‐. p. i. n. g. PY - 2019 DA - 2019// TI - Plasma circular RNA panel to diagnose hepatitis B virus‐related hepatocellular carcinoma: A large‐scale, multicenter study JO - International Journal of Cancer VL - 146 UR - https://doi.org/10.1002/ijc.32647 DO - 10.1002/ijc.32647 ID - Yu2019 ER - TY - JOUR AU - Zhao, S. Y. AU - Wang, J. AU - Ouyang, S. B. AU - Huang, Z. K. AU - Liao, L. PY - 2018 DA - 2018// TI - Salivary Circular RNAs Hsa_Circ_0001874 and Hsa_Circ_0001971 as Novel Biomarkers for the Diagnosis of Oral Squamous Cell Carcinoma JO - Cell Physiol Biochem. VL - 47 UR - https://doi.org/10.1159/000491624 DO - 10.1159/000491624 ID - Zhao2018 ER - TY - JOUR AU - Liu, Y. T. AU - Han, X. H. AU - Xing, P. Y. AU - Hu, X. S. AU - Hao, X. Z. AU - Wang, Y. PY - 2019 DA - 2019// TI - Circular RNA profiling identified as a biomarker for predicting the efficacy of Gefitinib therapy for non-small cell lung cancer JO - J Thorac Dis. VL - 11 UR - https://doi.org/10.21037/jtd.2019.05.22 DO - 10.21037/jtd.2019.05.22 ID - Liu2019 ER - TY - JOUR AU - Shao, F. AU - Huang, M. AU - Meng, F. AU - Huang, Q. PY - 2018 DA - 2018// TI - Circular RNA Signature Predicts Gemcitabine Resistance of Pancreatic Ductal Adenocarcinoma JO - Front Pharmacol. VL - 9 UR - https://doi.org/10.3389/fphar.2018.00584 DO - 10.3389/fphar.2018.00584 ID - Shao2018 ER - TY - JOUR AU - Kun-Peng, Z. AU - Xiao-Long, M. AU - Lei, Z. AU - Chun-Lin, Z. AU - Jian-Ping, H. AU - Tai-Cheng, Z. PY - 2018 DA - 2018// TI - Screening circular RNA related to chemotherapeutic resistance in osteosarcoma by RNA sequencing JO - Epigenomics. VL - 10 UR - https://doi.org/10.2217/epi-2018-0023 DO - 10.2217/epi-2018-0023 ID - Kun-Peng2018 ER - TY - JOUR AU - Yu, W. AU - Peng, W. AU - Sha, H. AU - Li, J. PY - 2019 DA - 2019// TI - Hsa_circ_0003998 Promotes Chemoresistance via Modulation of miR-326 in Lung Adenocarcinoma Cells JO - Oncol Res. VL - 27 UR - https://doi.org/10.3727/096504018X15420734828058 DO - 10.3727/096504018X15420734828058 ID - Yu2019 ER - TY - JOUR AU - Shang, J. AU - Chen, W. M. AU - Wang, Z. H. AU - Wei, T. N. AU - Chen, Z. Z. AU - Wu, W. B. PY - 2019 DA - 2019// TI - CircPAN3 mediates drug resistance in acute myeloid leukemia through the miR-153-5p/miR-183-5p-XIAP axis JO - Exp Hematol. VL - 70 UR - https://doi.org/10.1016/j.exphem.2018.10.011 DO - 10.1016/j.exphem.2018.10.011 ID - Shang2019 ER - TY - JOUR AU - Huang, X. AU - Li, Z. AU - Zhang, Q. AU - Wang, W. AU - Li, B. AU - Wang, L. PY - 2019 DA - 2019// TI - Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression JO - Mol Cancer. VL - 18 UR - https://doi.org/10.1186/s12943-019-0969-3 DO - 10.1186/s12943-019-0969-3 ID - Huang2019 ER - TY - JOUR AU - Xue, M. AU - Li, G. AU - Fang, X. AU - Wang, L. AU - Jin, Y. AU - Zhou, Q. PY - 2019 DA - 2019// TI - hsa_circ_0081143 promotes cisplatin resistance in gastric cancer by targeting miR-646/CDK6 pathway JO - Cancer Cell Int VL - 19 UR - https://doi.org/10.1186/s12935-019-0737-x DO - 10.1186/s12935-019-0737-x ID - Xue2019 ER - TY - STD TI - Huang XX, Zhang Q, Hu H, Jin Y, Zeng AL, Xia YB, et al. A novel circular RNA circFN1 enhances cisplatin resistance in gastric cancer via sponging miR-182-5p. J Cell Biochem. 2020. In press. ID - ref202 ER - TY - JOUR AU - Xu, Q. Y. AU - Xie, M. J. AU - Huang, J. AU - Wang, Z. W. PY - 2019 DA - 2019// TI - Effect of circ MTHFD2 on resistance to pemetrexed in gastric cancer through regulating expression of miR-124 JO - Eur Rev Med Pharmacol Sci. VL - 23 ID - Xu2019 ER -